Aug 14, 2026 08:30AM
May 15, 2026 08:30AM
Mar 19, 2026 08:36AM
Aug 13, 2025 07:11PM
Aug 13, 2025 08:05AM
May 14, 2025 04:30PM
May 14, 2025 07:30AM Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 7, 2025 09:00AM
Mar 25, 2025 06:52AM
Mar 24, 2025 07:05AM
Mar 19, 2025 08:05AM
Nov 11, 2024 07:05AM
Nov 5, 2024 09:00AM
Aug 14, 2024 08:05AM Moleculin Reports Second Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024 07:30AM
May 8, 2024 08:45AM
Mar 25, 2024 07:30AM
Mar 25, 2024 07:30AM
Mar 22, 2024 04:05PM
Mar 20, 2024 07:30AM
Jan 24, 2024 08:50AM Moleculin Biotech (MBRX) Reports 2023 Year-End Annamycin Clinical Trials Preliminary Data
Jan 24, 2024 08:50AM
Nov 13, 2023 08:03AM
Nov 13, 2023 08:00AM
Nov 7, 2023 08:45AM
Aug 11, 2023 06:46AM
Aug 11, 2023 06:45AM
Aug 3, 2023 08:45AM Moleculin to Report Second Quarter Financial Results on August 11, 2023 and Host Conference Call and Webcast
May 11, 2023 07:10AM
May 11, 2023 07:05AM
May 4, 2023 08:35AM
Mar 23, 2023 07:10AM
Mar 23, 2023 07:10AM
Mar 15, 2023 08:30AM
Nov 10, 2022 04:05PM Moleculin Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
Nov 7, 2022 09:05AM
Aug 15, 2022 08:35AM
May 12, 2022 08:37AM
May 12, 2022 08:35AM
Mar 25, 2022 07:06AM
Mar 25, 2022 07:05AM
Nov 11, 2021 08:05AM Moleculin Reports Third Quarter 2021 Financial Results and Provides Programs Update
Aug 12, 2021 08:18AM
May 12, 2021 07:35AM
Mar 24, 2021 07:30AM
Nov 13, 2020 07:30AM
Aug 12, 2020 07:30AM
Mar 19, 2020 04:14PM
Nov 12, 2019 07:00AM Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2019
Aug 16, 2019 05:35PM

1,223,347 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All